Ligand to Report Second Quarter 2019 Results on July 30th
Go back to Ligand to Report Second Quarter 2019 Results on July 30th| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 289.07 -1.64 (0.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $290.71 | 52 Week High | $139.79 | |||
| Open | $289.11 | 52 Week Low | $82.07 | |||
| Day High | $293.37 | P/E | 672.26 | |||
| Day Low | $287.81 | EPS | $0.43 | |||
| Volume | 10,641 | |||||

